RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 6,750.00
-20.00 (-0.30%)
At close: Feb 13, 2026
RP Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 4,889 | -907.12 | 5,437 | 4,316 | 3,813 | 4,616 |
Depreciation & Amortization | 6,554 | 6,818 | 6,048 | 5,403 | 5,203 | 4,414 |
Loss (Gain) From Sale of Assets | -103.86 | 9.24 | - | -150.06 | 4.31 | -4.68 |
Stock-Based Compensation | - | - | -5.77 | 10.54 | 14.57 | 106.91 |
Provision & Write-off of Bad Debts | 45.86 | 2.7 | 0.09 | -26.95 | -36.16 | 58.3 |
Other Operating Activities | 1,685 | 1,794 | 2,106 | 7,149 | 3,781 | 1,114 |
Change in Accounts Receivable | -446.2 | 2,334 | 777.83 | -1,651 | -4,355 | -5,601 |
Change in Inventory | 529.86 | 10,245 | 3,755 | -16,021 | -6,180 | -3,610 |
Change in Accounts Payable | 2,802 | -3,406 | -9,044 | 5,252 | 9,117 | 5,728 |
Change in Other Net Operating Assets | -1,604 | -3,366 | 1,505 | -3,125 | -1,902 | -367.03 |
Operating Cash Flow | 14,352 | 13,524 | 10,580 | 1,155 | 9,459 | 6,455 |
Operating Cash Flow Growth | 0.65% | 27.82% | 816.03% | -87.79% | 46.55% | -3.40% |
Capital Expenditures | -5,081 | -5,853 | -11,123 | -5,147 | -7,246 | -11,461 |
Sale of Property, Plant & Equipment | 16.95 | 14.38 | 69.73 | 165.55 | - | 22.01 |
Sale (Purchase) of Intangibles | -633.65 | -157.78 | -41.02 | -132.18 | -24.59 | -242.98 |
Investment in Securities | 10,883 | 4,405 | -7,803 | -7.2 | 308.64 | 5,573 |
Other Investing Activities | -201.79 | 390.45 | -6.67 | -218.69 | -204.13 | 1,463 |
Investing Cash Flow | 4,384 | -1,501 | -18,264 | -5,939 | -7,166 | -4,603 |
Short-Term Debt Issued | - | 21,000 | - | 14,500 | 23,235 | 17,500 |
Long-Term Debt Issued | - | - | - | - | - | 3,500 |
Total Debt Issued | 16,000 | 21,000 | - | 14,500 | 23,235 | 21,000 |
Short-Term Debt Repaid | - | -21,000 | -5,000 | -14,500 | -26,104 | -14,256 |
Long-Term Debt Repaid | - | -665.09 | -919.92 | -453 | -522.83 | -2,583 |
Total Debt Repaid | -25,634 | -21,665 | -5,920 | -14,953 | -26,627 | -16,840 |
Net Debt Issued (Repaid) | -9,634 | -665.09 | -5,920 | -453 | -3,392 | 4,160 |
Issuance of Common Stock | - | - | - | 16,287 | - | - |
Dividends Paid | - | -432.49 | - | - | - | - |
Other Financing Activities | - | - | -3.79 | -502.46 | - | - |
Financing Cash Flow | -9,634 | -1,098 | -5,924 | 15,332 | -3,392 | 4,160 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.32 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | -0 | - |
Net Cash Flow | 9,101 | 10,925 | -13,608 | 10,547 | -1,099 | 6,011 |
Free Cash Flow | 9,270 | 7,670 | -543.31 | -3,992 | 2,213 | -5,006 |
Free Cash Flow Margin | 6.91% | 6.19% | -0.36% | -2.89% | 1.93% | -5.11% |
Free Cash Flow Per Share | 1070.03 | 886.77 | -58.16 | -560.54 | 336.69 | -752.72 |
Cash Interest Paid | 1,055 | 1,316 | 1,816 | 989.75 | 638.38 | 532.4 |
Cash Income Tax Paid | 415.59 | 439.62 | 992.04 | 246.9 | 122.34 | 152.9 |
Levered Free Cash Flow | 5,475 | 6,556 | -6,112 | -3,592 | -1,246 | -11,456 |
Unlevered Free Cash Flow | 6,092 | 7,338 | -4,990 | -2,852 | -633.95 | -10,754 |
Change in Working Capital | 1,282 | 5,807 | -3,006 | -15,546 | -3,321 | -3,849 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.